Heart check: prostate cancer treatment may impact cardiac health

NCT ID NCT03275181

Completed Knowledge-focused Sponsor: Kansas State University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study looked at whether androgen deprivation therapy (ADT), a common hormone treatment for prostate cancer, affects how well the heart pumps. Researchers compared heart function in 18 men: some who had ADT, some who didn't, and some without cancer. They used ultrasound and exercise tests to measure heart performance. The goal is to find ways to protect heart health in prostate cancer survivors.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to better heart health monitoring and lifestyle advice for prostate cancer patients on hormone therapy.
What could go wrong: This is a small, completed study with only 18 participants, so results may not apply to everyone. It only measures heart function, not long-term outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PROSTATE CANCER

Contacts and locations

Locations

Kansas State University - Clinical Integrative Physiology Laboratory

Manhattan, Kansas, 66506, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.